Current Location: Advantages
Cell Drug
Cell Drug

  • Started conducting preclinical research on cell drugs in 2013;
  • Participated as a joint unit in the National Ministry of Science and Technology's major new drug development project "Preclinical and Clinical Research of Endometrial Regenerative Cell Drugs";
  • Undertake the construction of the "Common Key Technology Platform for Stem Cell Product Evaluation" for the Tianjin New Drug Creation Technology Major Project;
  • Establish a professional cellular drug evaluation technology platform, covering comprehensive evaluations of pharmacology, pharmacokinetics, and toxicology;
  • Provide research and development services that support clinical research filing and clinical trial registration;
  • Provided product research and development services to more than 50 domestic cell drug research enterprises, helping to obtain implied licenses for 7 clinical trials;
  • Director of the China Stem Cell Industry Alliance;
  • Partner of Tianjin Cell Ecology Haihe Laboratory.

服务项目

Pharmacodynamics

In vitro research

Multiple genus animal models

Pharmacokinetics

Fluorescence quantitative PCR

Flow cytometry

Chemiluminescence method

Animal live imaging

荧光染料标记、荧光蛋白标记、同位素标记

Non-clinical safety evaluation (GLP)

Safety pharmacology

Single/repeated administration toxicity

(rodents/non-rodents)

Immunogenicity and Immunotoxicity

Tumorigenic/tumorigenic/pro tumorigenic

Reproductive toxicity (Stage I, II, III)

Genetic toxicity

Special safety (irritation, allergies, hemolysis)

Toxicokinetics

Tianjin Tiancheng Drug Assessment Research Co.,Ltd.

Address:No.308,Huiren Avenue,Binhai Science and Technology Park,Binhai High-Tech Industrial Development Area,Tianjin

Tel:022-84845325

E-mail:BD@tipr.com.cn

Wechat:tjtccro

Tianjin Tiancheng Drug Assessment Research Co.,Ltd.

Address:No.308,Huiren Avenue,Binhai Science and Technology Park,Binhai High-Tech Industrial Development Area,Tianjin

Tel:022-84845325

E-mail:BD@tipr.com.cn

Wechat:tjtccro

津ICP备2021003365号-1